Snow Leopard
Senior Member (Voting Rights)
You seem to know a lot about this stuff. What do you make of this:
https://futurism.com/neoscope/pfizer-covid-vaccine-effective-one-shot
I also read something about it having 89/91% efficacy after one shot in a trial in Israel.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00448-7/fulltext
~90% effective in whom?
Efficacy figures that aren't based on randomised clinical trials and where there are significant differences in demographics aren't comparable (for example claims that the AZ vaccine has over 70%+ efficacy against symptomatic disease, when those subgroups where that was found were younger/healthier). Also note the short-term followups. In the long term, there is a tendency for regression to the mean and I'd expect lower figures simply for that reason.
The raw figures in the study you linked was 75% in the second week, but note that this was in healthy health-care workers. The efficacy in the elderly and the most vulnerable is always lower. So while the overall efficacy (against symptomatic disease) for two doses versus one may look like it is only a few higher percent overall, the gap is likely to be significantly higher in the most vulnerable. We won't really ever know for sure exactly how much difference as there will never be larger randomised trials.